Trial intelligence / Profile preview

Transdermal betamethasone dipropionate hydrogel patch for chronic hand eczema

TCTR20220413003Phase 4Completed

Sponsor
Faculty of Medicine, Srinakharinwirot University
Start
May 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of betamethasone dipropionate in chronic hand dermatitis (CHE), sponsored by Faculty of Medicine, Srinakharinwirot University. Started May 2022; status: completed.

02

Drugs

betamethasone dipropionate
03

Conditions

chronic hand dermatitis (CHE)

Beyond the preview

Go deeper on TCTR20220413003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220413003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call